| Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis 2005 · BCAA group · Patients with decompensated cirrhosis; age and sex not reported | 12 g | 2 years | — |
| Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance 2013 · BCAA-treated group · People with hepatocellular carcinoma after local curative radiofrequency ablation; age and sex range not specified | 12 g | 5 years | — |
| A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO) 2025 · NEXTAC arm · Adults aged 70 years or older with advanced pancreatic cancer or non-small cell lung cancer, scheduled for systemic cancer therapy | 2.5 g | 12 weeks | 64 |
| Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery 1997 · oral BCAAs · Patients after curative resection of hepatocellular carcinoma, including patients with cirrhosis | 100 g | 1 year | 75 |
| Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis 2018 · BCAAs+HPHF diet intervention group · Patients with cirrhosis | 110 g | 26 weeks | 37 |
| Effectiveness of Protein-enriched oral nutritional supplements on muscle function in middle-aged and elderly women: A randomized controlled trial 2025 · test group · Women aged 50–80 years; generally healthy, without clinical malnutrition or a stated diagnosed condition | 4 g | 12 weeks | 33 |
| Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group 1990 · branched-chain amino acids · Adults with cirrhosis and chronic hepatic encephalopathy; age and sex not reported | 240 mg/kg | 90 days | 30 |
| A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status 2009 · oral BCAA group · Adults with Child class A cirrhosis without major complications | 12.5 g | 1168 days | 27 |
| Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial 2023 · BCAA group · Adults aged 18–75 with frail, stable Child-Pugh A or B cirrhosis | 100 g | 16 weeks | 27 |
| Effects of branched-chain amino acids on changes in body composition during the recovery period following tonsillectomy 2025 · Experimental · Adults aged 20–40 scheduled for tonsillectomy; men and women without metabolic or bleeding disorders | 8 g | 3 weeks | 24 |
| Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects 2009 · BCAA · healthy men, mean age 35.5 years | 60 g | 1 day | 22 |
| The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study 2017 · active intervention · Adults with liver cirrhosis without clinically manifest hepatic encephalopathy | 17 g | 90 days | 22 |
| Effects of Branched-Chain Amino Acids on Skeletal Muscle, Glycemic Control, and Neuropsychological Performance in Elderly Persons with Type 2 Diabetes Mellitus: An Exploratory Randomized Controlled Trial 2022 · BCAA group · Adults aged 65 to under 80 years with type 2 diabetes | 8 g | 24 weeks | 21 |
| Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men 2003 · high-dose branched-chain amino acids · Men with psychiatric disorders and tardive dyskinesia, with long histories of antipsychotic treatment | 666 mg/kg | 3 weeks | 18 |
| Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis 2001 · BCAA supplementation · Adults aged over 70 years with malnutrition, anorexia and chronic haemodialysis | 12 g | 26 weeks | 14 |
| Branched-chain amino acid supplementation before squat exercise and delayed-onset muscle soreness 2010 · BCAA trial · 12 young, healthy, untrained women | 100 mg/kg | 1 day | 12 |
| Effect of Timing of Branched-Chain Amino Acid Supplementation on Muscle Recovery after Resistance Training in Healthy Males 2025 · BCAA-PRE group · Healthy male college students, mean age about 23 years, with no athletic training experience | 40 mg/kg | 1 day | 12 |
| Effect of Timing of Branched-Chain Amino Acid Supplementation on Muscle Recovery after Resistance Training in Healthy Males 2025 · BCAA-POST group · Healthy male college students, mean age about 23 years, with no athletic training experience | 40 mg/kg | 1 day | 12 |
| Branched-chain amino acid therapy for spinocerebellar degeneration: a pilot clinical crossover trial 1999 · BCAA-rich solution · Adults with spinocerebellar degeneration; 7 male and 4 female, mean age 60 years | 200 mL | 7 days | 11 |
| Branched-chain aminoacid supplementation attenuates a decrease in power-producing ability following acute strength training 2016 · BCAA · Resistance-trained males | 20 g | 1 day | 11 |
| Branched-Chain Amino Acid Supplementation Enhances Substrate Metabolism, Exercise Efficiency and Reduces Post-Exercise Fatigue in Active Young Males 2025 · BCAA group · Healthy, active male college students; young adults, with no diagnosed condition stated | 400 mg/kg | 4 days | 11 |
| Effect of acute and chronic branched-chain amino acids on energy metabolism and muscle performance 2003 · chronic BCAA supplementation · 10 healthy male volunteers | 14.4 g | 30 days | 10 |
| The effect of branched chain amino acids on psychomotor performance during treadmill exercise of changing intensity simulating a soccer game 2011 · BCAA trial · Male soccer players; age and health condition not specified | 7 g | 1 day | 10 |
| Effect of Branched-Chain Amino Acid Supplementation on Recovery Following Acute Eccentric Exercise 2018 · BCAA group · Young resistance-trained males, mean age 22.3 years, completing an acute eccentric exercise protocol | 220 mg/kg | 8 days | 10 |
| Omega-3 fatty acids enhance the beneficial effect of BCAA supplementation on muscle function following eccentric contractions 2022 · BCAA group · Healthy, untrained men aged 19–21 years | 9.6 g | 3 days | 10 |
| Additional effects of taurine on the benefits of BCAA intake for the delayed-onset muscle soreness and muscle damage induced by high-intensity eccentric exercise 2013 · BCAA alone · Untrained male volunteers | 9.6 g | 18 days | 9 |
| The effects of bolus supplementation of branched-chain amino acids on skeletal muscle mass, strength, and function in patients with rheumatic disorders during glucocorticoid treatment 2017 · BCAA (+) group · Patients with rheumatic disorders treated with prednisolone at ≥10 mg/day; age and sex not reported | 12 g | 12 weeks | 9 |
| Effects of a branched-chain amino acid drink in mania 2003 · BCAA · Patients with mania | 60 g | 7 days | — |
| In a single-blind, matched group design: branched-chain amino acid supplementation and resistance training maintains lean body mass during a caloric restricted diet 2016 · BCAA group · Resistance-trained males aged 21–28 years, following a calorically restricted diet and resistance-training program; no diagnosed condition stated | 28 g | 8 weeks | — |
| Effect of BCAA supplement timing on exercise-induced muscle soreness and damage: a pilot placebo-controlled double-blind study 2018 · PRE group · Young men aged 21.5±0.4 years performing eccentric exercise | 9.6 g | 7 days | — |
| Effect of BCAA supplement timing on exercise-induced muscle soreness and damage: a pilot placebo-controlled double-blind study 2018 · POST group · Young men aged 21.5±0.4 years performing eccentric exercise | 9.6 g | 7 days | — |
| Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults 2024 · 15 g BCAA treatment daily · Participants aged 11–34 with concussion | 15 g | 3 weeks | — |
| Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults 2024 · 30 g BCAA treatment daily · Participants aged 11–34 with concussion | 30 g | 3 weeks | — |
| Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults 2024 · 45 g BCAA treatment daily · Participants aged 11–34 with concussion | 45 g | 3 weeks | — |
| Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults 2024 · 54 g BCAA treatment daily · Participants aged 11–34 with concussion | 54 g | 3 weeks | — |
| Effects of branched chain amino acids, l-citrulline, and alpha-glycerylphosphorylcholine supplementation on exercise performance in trained cyclists: a randomized crossover trial 2023 · supplement · Men aged 30–60 who were trained cyclists with at least 5 years of consistent cycling training | 8 g | 7 days | 30 |
| The Effect of Branched Chain Amino Acids-Enriched Nutritional Supplements on Activities of Daily Living and Muscle Mass in Inpatients with Gait Impairments: A Randomized Controlled Trial 2019 · RJ group · Adult inpatients aged 20 years or older with gait impairments admitted to acute and convalescent rehabilitation wards | 5 g | 58 days | 29 |
| Glycine increases fat-free mass in malnourished haemodialysis patients: a randomized double-blind crossover trial 2021 · BCAA supplementation · Adults with protein-energy wasting undergoing chronic haemodialysis; mean age 61.2 years among analysed participants, women and men | 14 g | 120 days | 27 |
| Branched-chain amino acids and arginine improve performance in two consecutive days of simulated handball games in male and female athletes: a randomized trial 2015 · AA trial (BCAA + arginine) · Well-trained male and female handball players aged about 20–21 years, competing at national or international level, without known cardiovascular disease risks or musculoskeletal injuries | 170 mg/kg | 2 days | 22 |
| Branched-chain amino acid supplementation improves cycling performance in untrained cyclists 2021 · BCAA · Recreationally active men; mean age 24.7 years; no specific condition stated | 84 mg/kg | 1 day | 18 |
| Omega-3 fatty acids enhance the beneficial effect of BCAA supplementation on muscle function following eccentric contractions 2022 · BCAA+FO group · Healthy, untrained men aged 19–20 years | 9.6 g | 61 days | 10 |
| Additional effects of taurine on the benefits of BCAA intake for the delayed-onset muscle soreness and muscle damage induced by high-intensity eccentric exercise 2013 · TAU and BCAA · Untrained male volunteers | 9.6 g | 18 days | 9 |
| Prevention of perceptual-motor decline by branched-chain amino acids, arginine, citrulline after tennis match 2017 · AA trial · Nine male tennis players | 170 mg/kg | 1 day | 9 |
| The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision-making 2005 · BCAA/TRP mixture · Healthy adult volunteers; age and sex not specified | 60 g | 1 day | — |
| The effects of protein and amino acid supplementation on performance and training adaptations during ten weeks of resistance training 2006 · WBG · Resistance-trained males, mean age 31 years, undergoing resistance training | 3 g | 10 weeks | — |
| [Impact of glutamine, eicosapntemacnioc acid, branched-chain amino acid supplements on nutritional status and treatment compliance of esophageal cancer patients on concurrent chemoradiotherapy and gastric cancer patients on chemotherapy] 2015 · experimental group · Esophageal and gastric cancer patients receiving concurrent chemoradiotherapy or chemotherapy | 8 g | — | — |
| Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients 2015 · Control group, BCAA+ patients · Japanese adults with intermediate-stage hepatocellular carcinoma and liver cirrhosis undergoing TACE; already receiving BCAA granules | 4 g | 14 weeks | — |
| The Weight Loss Effects of Branched Chain Amino Acids and Vitamin B6: A Randomized Controlled Trial on Obese and Overweight Women 2018 · BCAA with vitamin B6 · Overweight and obese women (BMI 25–34.9 kg/m²) | 6 g | 4 weeks | — |
| Combined Effect of Arginine, Valine, and Serine on Exercise-Induced Fatigue in Healthy Volunteers: A Randomized, Double-Blinded, Placebo-Controlled Crossover Study 2019 · AA granule · Healthy men aged 30–59 years | 2.2 g | 2 weeks | 39 |
| The Combined Use of Hydroxymethylbutyrate and Branched-Chain Amino Acids to Counteract Uremic Sarcopenia 2026 · FFSMP · Adults aged 45–80, men and women, with end-stage kidney disease receiving hemodialysis | 5 g | 90 days | 24 |
| The Effects of Timing of a Leucine-Enriched Amino Acid Supplement on Body Composition and Physical Function in Stroke Patients: A Randomized Controlled Trial 2020 · breakfast group · Adults aged 40 years and older admitted for rehabilitation after cerebral infarction, cerebral hemorrhage, or subarachnoid hemorrhage | 125 mL | 60 days | 23 |
| The Effects of Timing of a Leucine-Enriched Amino Acid Supplement on Body Composition and Physical Function in Stroke Patients: A Randomized Controlled Trial 2020 · post-exercise group · Adults aged 40 years and older admitted for rehabilitation after cerebral infarction, cerebral hemorrhage, or subarachnoid hemorrhage | 125 mL | 60 days | 23 |
| A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS) 2023 · Active formulation · Exercise-trained adults aged 18–65 in good health who reported exercising at least 3 times weekly for at least 30 minutes per session during the prior year; participants underwent experimental induction of delayed onset muscle soreness. | 7.6 g | 4 days | 20 |
| Branched-chain amino acids, arginine, citrulline alleviate central fatigue after 3 simulated matches in taekwondo athletes: a randomized controlled trial 2016 · AA trial · Male taekwondo athletes, age 20.0 ± 0.8 years, competing at national or international level | 170 mg/kg | 1 day | 12 |
| Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients 2015 · L-carnitine group, BCAA+ patients · Japanese adults with intermediate-stage hepatocellular carcinoma and liver cirrhosis undergoing TACE; already receiving BCAA granules | 4 g | 14 weeks | — |
| Branched Chain Amino Acid Supplementation to a Hypocaloric Diet Does Not Affect Resting Metabolic Rate but Increases Postprandial Fat Oxidation Response in Overweight and Obese Adults after Weight Loss Intervention 2021 · BCAA · Chinese men and women aged 21–45 years with overweight or obesity (BMI 25–36 kg/m²), without existing medical conditions | 100 mg/kg | 16 weeks | 35 |
| A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma 2009 · BCAA group · Patients with liver cirrhosis and hepatocellular carcinoma undergoing trans-arterial chemoembolization; age and sex not reported | 50 g | 15 days | 28 |
| Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment 2015 · BCAA group (study 2) · Adults with cirrhosis receiving endoscopic treatment for esophageal varices who had already received BCAA for at least a month | 12 g | 50 days | 24 |
| Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment 2015 · BCAA-EN group (study 2) · Adults with cirrhosis receiving endoscopic treatment for esophageal varices who had already received BCAA for at least a month | 12 g | 50 days | 24 |
| Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment 2015 · BCAA-EN group (study 1) · Adults with cirrhosis receiving endoscopic treatment for esophageal varices, not receiving BCAA before the study | 12 g | 7 days | 16 |
| A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function 2002 · 10 g branch chain amino acids · 12 healthy volunteers | 10 g | 1 day | 12 |
| A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function 2002 · 30 g branch chain amino acids · 12 healthy volunteers | 30 g | 1 day | 12 |
| A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function 2002 · 60 g branch chain amino acids · 12 healthy volunteers | 60 g | 1 day | 12 |
| Effect of acute and chronic branched-chain amino acids on energy metabolism and muscle performance 2003 · acute BCAA group · 12 healthy male volunteers | 14.4 g | 2 days | 12 |
| Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice 2015 · BCAA group · Adults aged 65 years or older with HCV-related advanced fibrosis and low BCAA-to-tyrosine ratio; men and women | 12 g | 48 weeks | 12 |
| The Effects of Omega-3 and Branched-Chain Amino Acids Supplementation on Serum Apoptosis Markers Following Acute Resistance Exercise in Old Men 2019 · BCAA supplementation · Men aged 62.8 ± 2.2 years undergoing acute resistance exercise | 20 g | 7 days | 11 |
| Influence of branched-chain amino acid supplementation on urinary protein metabolite concentrations after swimming 2006 · BCAA group · Male university students aged 19–22 years majoring in physical education | 12 g | 15 days | 10 |
| The biphasic activity of autophagy and heat shock protein response in peripheral blood mononuclear cells following acute resistance exercise in resistance-trained males 2024 · BCAA supplementation group · Resistance-trained males, mean age 22.3 years | 220 mg/kg | 8 days | 10 |
| Effects of high-protein intake on bone turnover in long-term bed rest in women 2017 · HiPROT · Women participating in a 60-day head-down-tilt bed-rest study; age and health status not specified | 720 mg | 60 days | 8 |
| Short-term effects of branched-chain amino acids on liver function tests in cirrhotic patients 2000 · group I · Ambulatory patients with cirrhosis; age and sex not reported | 150 g | 4 weeks | — |
| Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine 2004 · 20 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported | 20 mg/kg | — | — |
| Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine 2004 · 30 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported | 30 mg/kg | — | — |
| Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine 2004 · 50 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported | 50 mg/kg | — | — |
| Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine 2004 · 60 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported | 60 mg/kg | — | — |
| Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine 2004 · 70 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported | 70 mg/kg | — | — |
| Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine 2004 · 90 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported | 90 mg/kg | — | — |
| Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine 2004 · 110 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported | 110 mg/kg | — | — |
| Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine 2004 · 130 mg·kg⁻¹·day⁻¹ BCAA mixture · Patients with classical maple syrup urine disease; age and sex not reported | 130 mg/kg | — | — |
| Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis 2009 · BCAA group · Patients with HCV-related cirrhosis and serum albumin below 4.0 g/dl | 14.2 g | 2 years | — |
| Effects of branched-chain amino acids on glucose metabolism in obese, prediabetic men and women: a randomized, crossover study 2019 · BCAA supplement · obese men and women with prediabetes; ages not reported | 20 g | 4 weeks | — |
| Effect of Oral Branched-Chain Amino Acids on Serum Albumin Concentration in Heart Failure Patients with Hypoalbuminemia: Results of a Preliminary Study 2018 · BCAA group · Adults aged 20 years or older hospitalized with decompensated heart failure and hypoalbuminemia (serum albumin below 3.5 g/dL) | 12 g | 18 days | 7 |
| Plasma levels of adrenaline, noradrenaline, dopamine, serotonin, and cortisol in sarcopenia: comparison with non-sarcopenic individuals and the impact of resistance exercise and nutrition interventions 2025 · Combined exercise and nutritional intervention (sarcopenic participants; early versus delayed intervention trial) · Adults older than 65 years with sarcopenia | 7.2 g | 12 weeks | 57 |
| Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial 2015 · supplement group · HCV-infected patients | 6.4 g | 60 days | 26 |
| Cardiac atrophy in women following bed rest 2007 · protein plus branched-chain amino acid supplementation · Healthy young women, mean age 32.1 years, undergoing 60 days of head-down tilt bed rest | 7.2 g | 60 days | 8 |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 5 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 5 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 10 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 10 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 15 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 15 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 20 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 20 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 25 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 25 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 30 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 30 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 35 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 35 mg/kg | 7 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 1: leucine 40 mg/kg/day, valine 80 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1 | 80 mg/kg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 1: leucine 15 mg/kg/day, valine 80 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1 | 80 mg/kg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 1: leucine 40 mg/kg/day, valine 20 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1 | 20 mg/kg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 1: leucine 15 mg/kg/day, valine 20 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1 | 20 mg/kg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 2: leucine 15 mg/kg/day, valine 20 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; five subjects were in phase 2 | 20 mg/kg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 2: leucine 40 mg/kg/day, valine 20 mg/kg/day, isoleucine 20 mg/kg/day · Healthy young adult men; five subjects were in phase 2 | 20 mg/kg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 2: leucine 15 mg/kg/day, valine 20 mg/kg/day, isoleucine 20 mg/kg/day · Healthy young adult men; five subjects were in phase 2 | 20 mg/kg | 5 days | — |
| Enhanced serum levels of tumor necrosis factor-α, interleukin-1β, and -6 in sarcopenia: alleviation through exercise and nutrition intervention 2023 · Early intervention group · Adults aged 65 years and older with sarcopenia | 7.2 g | 12 weeks | — |
| Enhanced serum levels of tumor necrosis factor-α, interleukin-1β, and -6 in sarcopenia: alleviation through exercise and nutrition intervention 2023 · Delayed intervention group · Adults aged 65 years and older with sarcopenia | 7.2 g | 12 weeks | — |
| A multi-nutrient supplement reduced markers of inflammation and improved physical performance in active individuals of middle to older age: a randomized, double-blind, placebo-controlled study 2011 · BioCharge multi-nutrient supplement · Healthy, recreationally active men and women aged 40–70 years | 3 g | 4 weeks | 31 |
| Dileucine-supplemented essential amino acids support whole-body anabolism after resistance exercise and serum-stimulated cell-based anabolism 2025 · Branched-chain amino acid (BCAA) supplement · Healthy recreationally active adults, 27.0 ± 4.7 years old; 8 men and 4 women | 1.5 g | 1 day | 12 |
| Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis 2020 · AXA1665 14.7 g t.i.d. + SOC (high-dose group) · Adults aged 18–75, male and female, with Child–Pugh A or B cirrhosis | 6.67 g | 15 days | 9 |
| The effect of multi-ingredient intra- versus extra-cellular buffering supplementation combined with branched-chain amino acids and creatine on exercise-induced ammonia blood concentration and aerobic capacity in taekwondo athletes 2021 · BA (intracellular buffering) · Elite taekwondo athletes aged 18–35 years, male and female, healthy and highly trained | 11 g | 8 weeks | 9 |
| The effect of multi-ingredient intra- versus extra-cellular buffering supplementation combined with branched-chain amino acids and creatine on exercise-induced ammonia blood concentration and aerobic capacity in taekwondo athletes 2021 · ALK (extracellular buffering) · Elite taekwondo athletes aged 18–35 years, male and female, healthy and highly trained | 11 g | 8 weeks | 9 |
| Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis 2020 · AXA1665 4.9 g t.i.d. + SOC (low-dose group) · Adults aged 18–75, male and female, with Child–Pugh A or B cirrhosis | 6.67 g | 15 days | 8 |